On May 5, 2025, Bristol Myers Squibb said it will invest $40 billion in the U.S. over the next five years, as it seeks to expand its research and manufacturing presence in the country amid tariff threats.

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News, and was later confirmed to Reuters by a company spokesperson.

n the Op-Ed, Boerner said the money will be spread across research and development, technology and domestic manufacturing, as U.S. drugmakers prepare to deal with the tariffs.